Intraductal papillary mucinous neoplasm with pseudomyxoma peritonei: a case report

Karim J Koussa1,2, Georges E Nassif1, Kendyll J Gartrelle1

  • 1Henry Ford Pancreatic Cancer Center, Detroit, Michigan, USA.

Abstract

Insights

Pseudomyxoma peritonei (PMP) from pancreatic intraductal papillary mucinous neoplasms (IPMNs) is rare. This case shows PMP can occur post-surgery, with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) as a viable treatment.

Area of Science:

  • Gastroenterology
  • Surgical Oncology

Background:

  • Pseudomyxoma peritonei (PMP) secondary to pancreatic intraductal papillary mucinous neoplasms (IPMNs) is exceptionally rare.
  • Diagnosis and management of PMP from IPMNs present significant challenges.